OBJECTIVES:The trial evaluated a new endoscopic treatment alternative for large benign prostatic hyperplasia (BPH) cases, the bipolar plasma enucleation of the prostate (BPEP), in terms of surgical efficiency, safety and short-term postoperative results.
MATERIALS AND METHODS:A total of 30 patients with prostates larger than 80 ml were included in the study. All cases were investigated preoperatively and at 1 and 3 months after surgery by international prostate symptoms score (IPSS), quality of life score (QoL), maximum flow rate (Q(max)) and abdominal and transrectal ultrasonography.
RESULTS:All procedures were successfully performed. The enucleation and morcellation times were 69.8 minutes and 18.5 minutes, while the morcellated tissue weight was 77 grams. The mean hemoglobin drop was 0.8 g/dl and the mean catheterization period and hospital stay were 26.5 hours and 2.3 days. The rate of early irritative symptoms was 10%. At 1 and 3 months, significant improvements were determined concerning the IPSS (5.3 and 4.8), QoL (1.2 and 1.1) and Q(max) (25.9 and 25.1 ml/s).
CONCLUSIONS: BPEP represents a promising endoscopic approach in large BPH cases, characterized by good surgical efficacy, reduced morbidity, fast postoperative recovery and satisfactory follow-up parameters.
Written by:
Geavlete B, Mulţescu R, Moldoveanu C, Stănescu F, Jecu M, Geavlete P. Are you the author?
Clinica de Urologie, Spitalul Clinic de Urgenţă "Sfântul Ioan", Bucureşti, România.
Reference: Chirurgia (Bucur). 2012 Jan-Feb;107(1):89-94.
PubMed Abstract
PMID: 22480122
Article in Romania
